CALR and MPL are not seen in PV, but the CALR mutation is present in 20‐25% of patients with ET and PMF and the MPL mutation in 3‐4% of patients with ET and 6‐7% in PMF (Tefferi & Pardanani, 2015). This evidence concerns the gene MPL and essential thrombocythemia.